A carregar...
Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele
This retrospective study was performed to verify the efficacy and safety of Onabotulinumtoxin A (BTX-A) in treating children with neurogenic bladder (NB) secondary to myelomeningocele (MMC) with detrusor overactivity/low compliance. From January 2002 to June 2011, 47 patients out of 68 with neuropat...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI
2012
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564065/ https://ncbi.nlm.nih.gov/pubmed/23274271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins5010016 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|